Government Affairs
Refine Search
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the opportunity to participate in the European Commission’s structured dialogue on supply chain security. 1 March 2021
Pharmaceutical
Brazil’s Ministry of Health (MoH) and Fiocruz last week launched a public notice for the construction of the Industrial Complex of Biotechnology in Health (Cibs, in the Portuguese acronym). 1 March 2021
Biosimilars
The US Association for Accessible Medicines (AAM) says it strongly supports President Joe Biden’s America’s Supply Chains Executive Order as an important step toward strengthening the US pharmaceutical supply chain and improving patient access to lower-cost generic and biosimilar medicines. 1 March 2021
Pharmaceutical
“Companies are borderless,” said Mark Duxon, chief executive of Transpharmation, a contract research organization (CRO) that has now added a Polish site to its UK and Irish facilities. 26 February 2021
Biotechnology
The US government has wasted no time after the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for bamlanivimab and etesevimab in COVID-19. 26 February 2021
Pharmaceutical
In an attempt to change India’s image as a manufacturer and exporter of low-value drugs, the government on Wednesday announced yet another $2.07 billion production-linked incentive (PLI) scheme for promoting manufacture of high-value products in the pharmaceutical sector. 24 February 2021
Biosimilars
Generics and biosimilars trade group Medicines for Europe has issued a statement calling for the expedition of digital regulatory infrastructure for medicines. 19 February 2021
Pharmaceutical
Through the Brexit deal struck between the UK and European Union (EU), the UK will be part of Horizon Europe, the EU’s next framework program for research and innovation. 17 February 2021
Biotechnology
In what is being considered a major fillip to the nation's biotechnology sector, the Indian government has decided to focus on product development commercialization biotech ecosystem in smaller tier-2 and tier-3 towns. A healthy engagement with biotech start-ups is being encouraged across the country, with an aim to take the industry to $150 billion by 2025, reports The Pharma Letter’s India correspondent. 17 February 2021
Generics
The Russian Ministry of Economy has prepared a draft order that will limit the ability of pharmaceutical companies to patent other forms of already known chemical compounds in Russia, according to recent statements by some senior state officials and local media, reports The Pharma Letter’s local correspondent. 17 February 2021
Pharmaceutical
Australia’s Pharmaceutical Benefits Advisory Committee (PBAC), a statutory committee established under the National Health Act 1953, today announced changes to its listing recommendations process. 15 February 2021
Generics
The National Pharmaceutical Pricing Authority (NPPA) has initiated 2116 cases of overcharging against Indian drug majors. 10 February 2021
Biotechnology
French vaccines developer Valneva today reported that the UK government has exercised its option to order a further 40 million doses of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001, for supply in 2022. 2 February 2021
Biotechnology
The Indian pharmaceutical sector is set to grow three-fold in the next decade, according to the country's Economic Survey. COVID-19 appears to have presented both an opportunity and a challenge for India to emerge as the 'pharmacy of the world', reports The Pharma Letter’s India correspondent. 1 February 2021
Pharmaceutical
Last week saw the UK’s AstraZeneca tell the European Commission that, due to glitches at its production facilities in Europe, it would be unable fully meet its supply commitment on its COVID-19 vaccine (AZD1222), which at that point had not been cleared for use by the European Medicines Agency. 30 January 2021
Biotechnology
While UK-based drugmaker AstraZeneca has not yet received European approval for its coronavirus vaccine, the trading bloc is already up in arms about the amount it can get its hands on. 28 January 2021
Biotechnology
Whether politicians choose to accept it or not, the countries of the world are engaged in a race to vaccinate their populations against the novel coronavirus - and winners are already beginning to emerge. 27 January 2021
Biotechnology
US President Joe Biden has announced plans to boost vaccine supplies to US states by around 1.4 million doses per week, as the country scrambles to protect itself from the novel coronavirus. 27 January 2021
Pharmaceutical
The number of pharmaceutical companies supplying their drugs for state needs as part of the most expensive procurement programs in Russia fell by 30% in 2020, as the level of competition in this market segment is tightened, according to recent statements, by some senior officials of the Russian Ministry of Health and some local media, reports The Pharma Letter’s local correspondent. 26 January 2021
Pharmaceutical
The United States will remain a member of the World Health Organization. 21 January 2021
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze